<DOC>
	<DOCNO>NCT02347033</DOCNO>
	<brief_summary>Generalised Anxiety Disorder ( GAD ) common , cause unpleasant symptom impair people 's functioning . It often chronic may accompany depression anxiety disorder . It currently clear whether medication psychological therapy provide well long term outcome respond simpler low intensity treatment propose compare clinical effectiveness pharmacological treatment ( drug Sertraline ) Cognitive Behavioural Therapy ( CBT ) intervention . Our hypothesis people GAD respond low intensity psychological intervention , CBT lead great improvement GAD symptom measure use GAD-7 scale 12 month follow-up Sertraline .</brief_summary>
	<brief_title>Trial Sertraline Versus Cognitive Behaviour Therapy Generalised Anxiety</brief_title>
	<detailed_description>The investigator propose undertake randomise control trial ( RCT ) compare clinical effectiveness term symptoms function pharmacological treatment ( SSRI Sertraline ) prescribe therapeutic dos , manualised psychological intervention ( Cognitive Behavioural Therapy , CBT ) deliver trained psychological therapist patient persistent generalise anxiety disorder ( GAD ) improve low intensity psychological intervention define NICE ( National Institute Clinical Effectiveness ) . The investigator recruit people via Increasing Access Psychological Therapies ( IAPT ) service 15 site England . People still score highly anxiety measure ( GAD-7 ) despite receive low intensity psychological intervention give brief fly trial . Names interested take part give write consent detail release pass research team IAPT staff also let research team know name participant 's general practice , permission . The research team contact potential participant offer appointment interview/assessment discus study , send patient information sheet reach least 48 hour beforehand . The study information explain medication evaluate , Sertraline , although currently license GAD recommend NICE basis effectiveness clinical trial study team available clarify issue arise . At baseline assessment patient ask give informed consent member research team medical suitability ( confirmed fax/secure email GP ) meeting inclusion/exclusion criterion check . Upon confirmation eligibility , baseline assessment carry member research team consent patient randomise receive either medication CBT . The Chief Investigator medically qualify person within research team review eligibility information confirm patient eligible . Eligible participant randomise via independent web-based computerised system one two intervention . The research team provide relevant contact details/instructions patient order initiate treatment . The trial intervention consist : ( ) The medication sertraline prescribe GP accord trial protocol match current clinical recommendation within dosage 25 150mg daily . We ask GPs review patient regularly ( least 6 time 12 month ) patient take medication year unless significant adverse effect . Side-effects regularly monitor . ( b ) The intervention CBT deliver high intensity therapist local IAPT service . They provide 14 16 session manualised treatment develop use GAD train delivery . The primary outcome GAD-7 score measure 12 month . Participants also ask complete outcome measure postal questionnaire 3 , 6 9 month , well range secondary outcome .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Aged 18 Positive score 10+ GAD7 Primary diagnosis GAD diagnose MINI Failure respond NICE define low intensity psychological intervention Inability complete questionnaire due insufficient English cognitive impairment ; Current major depression Other comorbid anxiety disorder ( ) severity distress participant GAD ; Significant dependence alcohol illicit drug ; Comorbid psychotic disorder , bipolar disorder ; Treatment antidepressant past 8 week high intensity psychological therapy within past 6 month ; Currently contraindicate medication : monoamine oxidase Inhibitors within past 14 day pimozide ; Patients poorly control epilepsy ; Known allergies Investigational Medicinal Product ( IMP ) excipients ; Concurrent enrolment another Investigational Medicinal Product trial ; Severe hepatic impairment ; Women currently pregnant plan pregnancy lactate Patient anticoagulant History bleeding disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Sertraline</keyword>
	<keyword>Selective Serotonin Reuptake Inhibitor ( SSRI )</keyword>
	<keyword>Cognitive Behavioural Therapy ( CBT )</keyword>
	<keyword>Increasing Access Psychological Therapies ( IAPT )</keyword>
</DOC>